Skip to main content
AI Market Summary
Loading market intelligence...
  • Sign in
    Welcome !
    My account
    Logout

Alexander & Baldwin, Inc. (ALEX) Stock Forecast 2025 - AI Price Prediction & Analysis

Alexander & Baldwin, Inc. (ALEX) AI Stock Price Forecast & Investment Analysis

Alexander & Baldwin, Inc. Stock Price Chart and Technical Analysis

Loading Alexander & Baldwin, Inc. interactive price chart and technical analysis...

Alexander & Baldwin, Inc. (ALEX) - Comprehensive Stock Analysis & Investment Research

Deep dive into Alexander & Baldwin, Inc.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about Alexander & Baldwin, Inc., including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For Alexander & Baldwin, Inc.: Alexander & Baldwin, Inc. operates in the Real Estate & Construction sector, making it an emerging small-cap investment.

Alexander & Baldwin, Inc. (Stock Symbol: ALEX) is a leading company in the Real Estate & Construction sector , specifically operating within the Real Estate Investment Trusts industry.

The organization employs approximately 806 professionals worldwide .

The company has established itself as an emerging investment opportunity with substantial growth potential.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing Alexander & Baldwin, Inc.'s revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Alexander & Baldwin, Inc.: With $218M in annual revenue and 19.6% net margin, the company demonstrates exceptional profitability.

Annual Revenue: $218 million generating a 19.6% net profit margin .

Market Capitalization: $1523 million - Classified as a small-cap investment offering high growth potential.

Return on Equity (ROE): 3.3% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for Alexander & Baldwin, Inc. stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Spearman correlation coefficient shows the statistical relationship between predictions and actual outcomes.

For Alexander & Baldwin, Inc.: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for Alexander & Baldwin, Inc. stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: Alexander & Baldwin, Inc.'s competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For Alexander & Baldwin, Inc.: Strong free cash flow generation demonstrates developing operational efficiency.

Alexander & Baldwin, Inc. strategically competes in the highly dynamic Real Estate Investment Trusts marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities .

The company demonstrates robust operational efficiency through strong free cash flow generation of $58 million annually, complemented by impressive -60.0% year-over-year cash flow growth.

The company maintains a healthy 26.0% gross margin, indicating strong pricing power and operational efficiency.

Alexander & Baldwin, Inc. (ALEX) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Alexander & Baldwin, Inc. stock analysis.

Loading Alexander & Baldwin, Inc. comprehensive fundamental analysis and insider trading data...

Deep dive into Alexander & Baldwin, Inc.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Alexander & Baldwin, Inc. stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Alexander & Baldwin, Inc.: With a P/E ratio of 20.76, the market moderately values the company's earnings.

P/E Ratio 20.76x
P/B Ratio 1.50x
Market Cap $1523M
Dividend Yield 4.30%
EPS $1.07
Book Value/Share $13.91
Revenue/Share $3.00
FCF/Share $0.94
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Alexander & Baldwin, Inc. converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Alexander & Baldwin, Inc.: An ROE of 3.3% indicates room for improvement in shareholder value creation.

ROE 3.3%
ROA 1.9%
ROIC 3.0%
Gross Margin 26.0%
Operating Margin 34.9%
Net Margin 19.6%
EBT Margin 9.6%
Tax Rate 7.4%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Alexander & Baldwin, Inc.'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Alexander & Baldwin, Inc.: A current ratio of 2.00 shows adequate liquidity.

Current Ratio 2.00x
Quick Ratio 0.77x
D/E Ratio 0.51x
Financial Leverage 1.73x
Interest Coverage 2.5x
Working Capital $102M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Alexander & Baldwin, Inc.'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Alexander & Baldwin, Inc.: Free cash flow of $58M provides flexibility for shareholder returns and growth investments.

Operating Cash Flow $111M
Free Cash Flow $58M
Capital Spending $-52M
OCF Growth YoY -60.0%
FCF Growth YoY -65.5%
FCF/Sales 14.8%
CapEx/Sales 13.1%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Alexander & Baldwin, Inc. uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Alexander & Baldwin, Inc.: An asset turnover of 0.21x suggests room for improvement in asset utilization.

Asset Turnover 0.21x
Receivables Turnover 11.2x
Inventory Turnover 10.0x
Fixed Assets Turnover 3.5x
Days Sales Outstanding 33 days
Days Inventory 37 days
Payables Period 18 days
Cash Conversion Cycle 51 days
Understanding Financial Statement Data

What these metrics mean: Key figures from Alexander & Baldwin, Inc.'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Alexander & Baldwin, Inc.: With annual revenue of $218M, Alexander & Baldwin, Inc. demonstrates solid business size.

Income Statement ($ Millions)
Total Revenue $218M
SG&A Expense $14M
Cost of Goods Sold $62M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 12%
Cash & Short-term Investments 2%
Total Liabilities 42%
Short-term Debt 7%
Accounts Receivable 3%
Inventory 1%
Dividend & Shareholder Information
Dividends Per Share $0.90
Payout Ratio 1.1%
Shares Outstanding 73M
Growth Metrics (YoY)
EPS Growth 3.5%

Latest Alexander & Baldwin, Inc. Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Alexander & Baldwin, Inc. (ALEX) stock price and investment outlook.

, source: Archaeology

Excavations in northern Greece are revealing the world that shaped the future king One October morning in 336 B.C., the small theater at Aigai, the ceremonial center of ancient Macedonia, began to ...

, source: Live Science

Alexander the Great ascended the Macedonian throne at age 20 and died just 12 years later, having conquered one of the largest empires in the ancient world. During that time, did he father any ...

, source: Smithsonian Magazine

One of the more impressive things about Alexander the Great is that the military genius did it all before the age of 32. While details differ, the general outline of Alexander’s death in the city of ...

, source: Forbes

(One in a series of conversations between historians James Romm [JR] and Paul A. Cartledge [PAC], editor and introduction-author, respectively, of the new Landmark Arrian: The Campaigns of Alexander, ...

, source: Live Science

Alexander the Great's empire stretched from the Balkans to modern-day Pakistan. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. Alexander the ...

, source: IGN

Alexander the Iron Fist is one of the many NPCs you'll encounter that has a side quest to complete in Elden Ring. For this part of our Elden Ring Wiki guide, you'll find details of where to find him, ...

Alexander & Baldwin, Inc. Competitors & Peer Analysis - Real Estate & Construction Sector

Comparative analysis of Alexander & Baldwin, Inc. against industry peers and competitors in the Real Estate & Construction sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
AAT Unlock Forecast - 30 Days FREE Trial $1172M 14.9x 1.0x
ABR Unlock Forecast - 30 Days FREE Trial $1736M 9.0x 0.6x
ABR-PD Unlock Forecast - 30 Days FREE Trial $3435M 17.7x 1.2x
ABR-PE Unlock Forecast - 30 Days FREE Trial $3356M 17.3x 1.1x
ABR-PF Unlock Forecast - 30 Days FREE Trial $4335M 22.3x 1.5x
ACR Unlock Forecast - 30 Days FREE Trial $175M 6.1x 0.4x
ACRE Unlock Forecast - 30 Days FREE Trial $287M 8.5x 0.6x
ACR-PC Unlock Forecast - 30 Days FREE Trial $186M 6.5x 0.4x
ACR-PD Unlock Forecast - 30 Days FREE Trial $164M 5.7x 0.4x
ADC Unlock Forecast - 30 Days FREE Trial $8189M 42.3x 1.4x
ADC-PA Unlock Forecast - 30 Days FREE Trial $1979M 10.2x 0.3x
AGNC Unlock Forecast - 30 Days FREE Trial $11070M 13.2x 1.0x
AGNCL Unlock Forecast - 30 Days FREE Trial $26657M 31.8x 2.3x
AGNCM Unlock Forecast - 30 Days FREE Trial $26378M 31.5x 2.3x
AGNCN Unlock Forecast - 30 Days FREE Trial $27214M 70.1x 2.4x
AGNCO Unlock Forecast - 30 Days FREE Trial $27205M 32.5x 2.4x
AGNCP Unlock Forecast - 30 Days FREE Trial $26732M 31.9x 2.3x
AHR Unlock Forecast - 30 Days FREE Trial $7697M 282.4x 2.9x
AHT Unlock Forecast - 30 Days FREE Trial $26M -1.5x -0.1x
AHT-PD Unlock Forecast - 30 Days FREE Trial $120M x x
AHT-PF Unlock Forecast - 30 Days FREE Trial $80M x x
AHT-PG Unlock Forecast - 30 Days FREE Trial $92M x x
AHT-PH Unlock Forecast - 30 Days FREE Trial $82M x x
AHT-PI Unlock Forecast - 30 Days FREE Trial $82M x x
AIV Unlock Forecast - 30 Days FREE Trial $812M 3.4x 13.1x
AKR Unlock Forecast - 30 Days FREE Trial $2598M 228.8x 1.2x
ALEX Unlock Forecast - 30 Days FREE Trial $1523M 20.8x 1.5x
ALX Unlock Forecast - 30 Days FREE Trial $1115M 30.4x 8.7x
AMH Unlock Forecast - 30 Days FREE Trial $11548M 22.5x 1.6x
AMH-PG Unlock Forecast - 30 Days FREE Trial $8442M 16.5x 1.2x
AMH-PH Unlock Forecast - 30 Days FREE Trial $8902M 17.4x 1.2x
AMT Unlock Forecast - 30 Days FREE Trial $84620M 28.8x 21.4x
APLE Unlock Forecast - 30 Days FREE Trial $2870M 16.4x 0.9x
ARE Unlock Forecast - 30 Days FREE Trial $7942M 55.8x 0.5x
ARI Unlock Forecast - 30 Days FREE Trial $1406M 10.2x 0.8x
ARR Unlock Forecast - 30 Days FREE Trial $1892M 29.3x 0.9x
ARR-PC Unlock Forecast - 30 Days FREE Trial $2353M 36.5x 1.1x
AVB Unlock Forecast - 30 Days FREE Trial $25048M 21.4x 2.1x
BDN Unlock Forecast - 30 Days FREE Trial $523M -5.2x 0.6x
BFS Unlock Forecast - 30 Days FREE Trial $779M 19.9x 2.5x
BFS-PD Unlock Forecast - 30 Days FREE Trial $504M 12.9x 1.6x
BFS-PE Unlock Forecast - 30 Days FREE Trial $534M 13.7x 1.7x
BHM Unlock Forecast - 30 Days FREE Trial $33M 41.9x 0.3x
BHR Unlock Forecast - 30 Days FREE Trial $183M -3.1x 0.9x
BHR-PB Unlock Forecast - 30 Days FREE Trial $1036M x 4.9x
BHR-PD Unlock Forecast - 30 Days FREE Trial $1271M x 6.0x
BMNM Unlock Forecast - 30 Days FREE Trial $23M 24.8x 1.0x
BNL Unlock Forecast - 30 Days FREE Trial $3343M 37.3x 1.2x
BRSP Unlock Forecast - 30 Days FREE Trial $754M -6.6x 0.8x
BRT Unlock Forecast - 30 Days FREE Trial $272M -37.6x 1.5x
BRX Unlock Forecast - 30 Days FREE Trial $7851M 23.6x 2.7x
BXMT Unlock Forecast - 30 Days FREE Trial $3491M 32.6x 1.0x
BXP Unlock Forecast - 30 Days FREE Trial $11311M 2366.0x 2.3x
CBL Unlock Forecast - 30 Days FREE Trial $1141M 9.1x 3.3x
CCI Unlock Forecast - 30 Days FREE Trial $39568M 36.6x 5.6x
CDP Unlock Forecast - 30 Days FREE Trial $3330M 21.3x 2.2x
CDR-PB Unlock Forecast - 30 Days FREE Trial $251M 2281.0x 42.9x
CDR-PC Unlock Forecast - 30 Days FREE Trial $230M 2088.9x 39.3x
CHCT Unlock Forecast - 30 Days FREE Trial $436M -220.9x 1.0x
CHMI Unlock Forecast - 30 Days FREE Trial $93M 8.7x 0.4x
CHMI-PA Unlock Forecast - 30 Days FREE Trial $763M 71.4x 3.3x
CHMI-PB Unlock Forecast - 30 Days FREE Trial $862M 80.7x 3.7x
CHTH Unlock Forecast - 30 Days FREE Trial $657M x 1.0x
CIM Unlock Forecast - 30 Days FREE Trial $1030M 18.5x 0.4x
CIMN Unlock Forecast - 30 Days FREE Trial $2046M 36.8x 0.8x
CIMO Unlock Forecast - 30 Days FREE Trial $2054M 36.9x 0.8x
CIM-PA Unlock Forecast - 30 Days FREE Trial $1776M 31.9x 0.7x
CIM-PB Unlock Forecast - 30 Days FREE Trial $1901M 34.2x 0.7x
CIM-PC Unlock Forecast - 30 Days FREE Trial $1770M 31.8x 0.7x
CIM-PD Unlock Forecast - 30 Days FREE Trial $1880M 33.8x 0.7x
CIO Unlock Forecast - 30 Days FREE Trial $281M -15.4x 0.5x
CIO-PA Unlock Forecast - 30 Days FREE Trial $1017M x 1.7x
CLDT Unlock Forecast - 30 Days FREE Trial $337M 38.6x 0.5x
CLDT-PA Unlock Forecast - 30 Days FREE Trial $963M 110.2x 1.3x
CLPR Unlock Forecast - 30 Days FREE Trial $55M -10.4x -20.5x
CMCT Unlock Forecast - 30 Days FREE Trial $3M -0.1x 0.0x
CMRF Unlock Forecast - 30 Days FREE Trial $1565M 213.8x 0.9x
COLD Unlock Forecast - 30 Days FREE Trial $3626M -26.5x 1.2x
CPT Unlock Forecast - 30 Days FREE Trial $11090M 41.2x 2.4x
CSR Unlock Forecast - 30 Days FREE Trial $1094M 35.9x 1.5x
CTO Unlock Forecast - 30 Days FREE Trial $581M 41.8x 1.0x
CTO-PA Unlock Forecast - 30 Days FREE Trial $700M x 1.3x
CTRE Unlock Forecast - 30 Days FREE Trial $8083M 30.9x 2.0x
CUBE Unlock Forecast - 30 Days FREE Trial $8328M 23.4x 3.0x
CUZ Unlock Forecast - 30 Days FREE Trial $4218M 73.2x 0.9x
CXW Unlock Forecast - 30 Days FREE Trial $1992M 18.2x 1.4x
DEA Unlock Forecast - 30 Days FREE Trial $1010M 72.9x 0.8x
DEI Unlock Forecast - 30 Days FREE Trial $1949M 87.7x 1.0x
DHC Unlock Forecast - 30 Days FREE Trial $1136M -1.7x 0.7x
DHCNI Unlock Forecast - 30 Days FREE Trial $4029M -10.4x 2.4x
DLR Unlock Forecast - 30 Days FREE Trial $52701M 37.7x 2.3x
DLR-PJ Unlock Forecast - 30 Days FREE Trial $7458M 5.3x 0.3x
DLR-PK Unlock Forecast - 30 Days FREE Trial $8250M 5.9x 0.4x
DLR-PL Unlock Forecast - 30 Days FREE Trial $7224M 5.2x 0.3x
DOC Unlock Forecast - 30 Days FREE Trial $11550M 78.3x 1.5x
DRH Unlock Forecast - 30 Days FREE Trial $1884M 29.5x 1.2x
DRH-PA Unlock Forecast - 30 Days FREE Trial $5185M 81.1x 3.3x
DTLAP Unlock Forecast - 30 Days FREE Trial $0M x x
DX Unlock Forecast - 30 Days FREE Trial $1972M 10.7x 3.4x
DX-PC Unlock Forecast - 30 Days FREE Trial $3791M 20.5x 6.5x
EARN Unlock Forecast - 30 Days FREE Trial $194M -11.6x 0.9x
EGP Unlock Forecast - 30 Days FREE Trial $9738M 39.2x 2.8x
ELME Unlock Forecast - 30 Days FREE Trial $1531M -114.5x 1.7x
ELS Unlock Forecast - 30 Days FREE Trial $12027M 20.2x 6.9x
EPR Unlock Forecast - 30 Days FREE Trial $3830M 19.2x 1.9x
EPR-PC Unlock Forecast - 30 Days FREE Trial $1790M 9.0x 0.9x
EPR-PE Unlock Forecast - 30 Days FREE Trial $2345M 11.8x 1.1x
EPR-PG Unlock Forecast - 30 Days FREE Trial $1575M 7.9x 0.8x
EPRT Unlock Forecast - 30 Days FREE Trial $6049M 25.2x 1.6x
EQIX Unlock Forecast - 30 Days FREE Trial $73672M 68.8x 5.2x
EQR Unlock Forecast - 30 Days FREE Trial $23194M 20.1x 2.1x
ESBA Unlock Forecast - 30 Days FREE Trial $1855M 31.1x x
ESRT Unlock Forecast - 30 Days FREE Trial $1873M 53.7x 1.8x
ESS Unlock Forecast - 30 Days FREE Trial $16592M 19.6x 3.0x
EXR Unlock Forecast - 30 Days FREE Trial $28543M 30.1x 2.1x
FBRT Unlock Forecast - 30 Days FREE Trial $887M 9.3x 0.6x
FBRT-PE Unlock Forecast - 30 Days FREE Trial $1774M 18.7x 1.2x
FCPT Unlock Forecast - 30 Days FREE Trial $2409M 22.1x 1.6x
FISK Unlock Forecast - 30 Days FREE Trial $1768M 29.7x x
FPI Unlock Forecast - 30 Days FREE Trial $435M 6.3x 434854.3x
FR Unlock Forecast - 30 Days FREE Trial $7706M 32.5x 2.9x
FREVS Unlock Forecast - 30 Days FREE Trial $0M 0.0x 0.0x
FRT Unlock Forecast - 30 Days FREE Trial $8590M 24.8x 2.7x
FRT-PC Unlock Forecast - 30 Days FREE Trial $1742M 5.0x 0.5x
FSP Unlock Forecast - 30 Days FREE Trial $100M -1.9x 0.2x
FVR Unlock Forecast - 30 Days FREE Trial $320M 1139.1x 0.8x
GEDC Unlock Forecast - 30 Days FREE Trial $8M x x
GIPR Unlock Forecast - 30 Days FREE Trial $5M -0.8x 17.0x
GLPI Unlock Forecast - 30 Days FREE Trial $12308M 15.9x 2.7x
GMRE Unlock Forecast - 30 Days FREE Trial $470M 188.2x 1.0x
GMRE-PA Unlock Forecast - 30 Days FREE Trial $323M 129.4x 0.7x
GNL Unlock Forecast - 30 Days FREE Trial $1825M -4.5x 1.1x
GNL-PA Unlock Forecast - 30 Days FREE Trial $4967M x 2.9x
GNL-PB Unlock Forecast - 30 Days FREE Trial $4799M x 2.8x
GNL-PD Unlock Forecast - 30 Days FREE Trial $5255M x 3.1x
GNL-PE Unlock Forecast - 30 Days FREE Trial $5048M x 3.0x
GPMT Unlock Forecast - 30 Days FREE Trial $126M -0.9x 0.2x
GPMT-PA Unlock Forecast - 30 Days FREE Trial $928M x 1.6x
GRP-UN Unlock Forecast - 30 Days FREE Trial $2621M x 3.0x
HHH Unlock Forecast - 30 Days FREE Trial $5022M 42.6x 1.3x
HIW Unlock Forecast - 30 Days FREE Trial $2833M 21.8x 1.2x
HLTC Unlock Forecast - 30 Days FREE Trial $219M x 0.4x
HST Unlock Forecast - 30 Days FREE Trial $12626M 17.1x 1.9x
ICRP Unlock Forecast - 30 Days FREE Trial $85M 27.9x 0.4x
ICR-PA Unlock Forecast - 30 Days FREE Trial $218M 71.4x 0.9x
IHT Unlock Forecast - 30 Days FREE Trial $11M -57.7x 2.8x
ILPT Unlock Forecast - 30 Days FREE Trial $377M -2.3x 0.8x
IMPM Unlock Forecast - 30 Days FREE Trial $2M x x
INN Unlock Forecast - 30 Days FREE Trial $557M 351.7x 0.6x
INN-PE Unlock Forecast - 30 Days FREE Trial $2081M 1314.0x 2.4x
INN-PF Unlock Forecast - 30 Days FREE Trial $2088M 1318.1x 2.4x
INRE Unlock Forecast - 30 Days FREE Trial $379M x 1.1x
IOR Unlock Forecast - 30 Days FREE Trial $76M 18.4x 0.6x
IRM Unlock Forecast - 30 Days FREE Trial $24630M 154.7x -41.7x
IRT Unlock Forecast - 30 Days FREE Trial $4048M 181.6x 1.2x
IVR Unlock Forecast - 30 Days FREE Trial $573M 10.8x 0.7x
IVR-PC Unlock Forecast - 30 Days FREE Trial $1737M 32.6x 2.3x
IVT Unlock Forecast - 30 Days FREE Trial $2254M 19.0x 1.3x
JBGS Unlock Forecast - 30 Days FREE Trial $1024M -11.3x 0.6x
KBSR Unlock Forecast - 30 Days FREE Trial $180M x 0.9x
KIM Unlock Forecast - 30 Days FREE Trial $13652M 22.8x 1.3x
KIM-PL Unlock Forecast - 30 Days FREE Trial $13761M 23.0x 1.3x
KIM-PM Unlock Forecast - 30 Days FREE Trial $14031M 23.4x 1.3x
KIM-PN Unlock Forecast - 30 Days FREE Trial $39494M 65.9x 3.8x
KRC Unlock Forecast - 30 Days FREE Trial $4787M 14.8x 0.9x
KREF Unlock Forecast - 30 Days FREE Trial $581M 952.5x 0.5x
KREF-PA Unlock Forecast - 30 Days FREE Trial $1183M x 1.0x
KRG Unlock Forecast - 30 Days FREE Trial $5058M 48.1x 1.6x
LADR Unlock Forecast - 30 Days FREE Trial $1436M 18.1x 1.0x
LAMR Unlock Forecast - 30 Days FREE Trial $13020M 30.0x 12.6x
LAND Unlock Forecast - 30 Days FREE Trial $326M 33.0x 0.5x
LANDM Unlock Forecast - 30 Days FREE Trial $904M 91.7x 1.4x
LANDO Unlock Forecast - 30 Days FREE Trial $689M 69.9x 1.0x
LANDP Unlock Forecast - 30 Days FREE Trial $690M 70.0x 1.0x
LFT Unlock Forecast - 30 Days FREE Trial $80M 8.1x 0.4x
LFT-PA Unlock Forecast - 30 Days FREE Trial $1115M 113.8x 4.9x
LINE Unlock Forecast - 30 Days FREE Trial $8406M x 1.0x
LOAN Unlock Forecast - 30 Days FREE Trial $56M 10.5x 1.3x
LTC Unlock Forecast - 30 Days FREE Trial $1642M 48.5x 1.7x
LXP Unlock Forecast - 30 Days FREE Trial $14703M 125.2x 7.1x
LXP-PC Unlock Forecast - 30 Days FREE Trial $13815M 117.7x 6.7x
MAA Unlock Forecast - 30 Days FREE Trial $15468M 27.8x 2.7x
MAA-PI Unlock Forecast - 30 Days FREE Trial $6191M 11.1x 1.1x
MAC Unlock Forecast - 30 Days FREE Trial $4785M -64.7x 1.9x
MDRR Unlock Forecast - 30 Days FREE Trial $15M -8.9x 1.4x
MDV Unlock Forecast - 30 Days FREE Trial $173M 122.6x 1.1x
MDV-PA Unlock Forecast - 30 Days FREE Trial $290M 205.5x 1.8x
MFA Unlock Forecast - 30 Days FREE Trial $981M 7.6x 0.5x
MFAN Unlock Forecast - 30 Days FREE Trial $2558M 19.9x 1.4x
MFAO Unlock Forecast - 30 Days FREE Trial $2566M 20.0x 1.4x
MFA-PB Unlock Forecast - 30 Days FREE Trial $2039M 15.9x 1.1x
MFA-PC Unlock Forecast - 30 Days FREE Trial $2371M 18.5x 1.3x
MITN Unlock Forecast - 30 Days FREE Trial $800M 16.1x 1.4x
MITP Unlock Forecast - 30 Days FREE Trial $801M 16.1x 1.4x
MITT Unlock Forecast - 30 Days FREE Trial $267M 5.4x 0.5x
MITT-PA Unlock Forecast - 30 Days FREE Trial $707M 14.2x 1.3x
MITT-PB Unlock Forecast - 30 Days FREE Trial $696M 14.0x 1.2x
MITT-PC Unlock Forecast - 30 Days FREE Trial $793M 16.0x 1.4x
MKZR Unlock Forecast - 30 Days FREE Trial $60M x 1.1x
MPW Unlock Forecast - 30 Days FREE Trial $3066M -1.3x 0.7x
NHI Unlock Forecast - 30 Days FREE Trial $3531M 24.0x 2.4x
NHPAP Unlock Forecast - 30 Days FREE Trial $547M x 0.9x
NHPBP Unlock Forecast - 30 Days FREE Trial $528M x 0.8x
NLCP Unlock Forecast - 30 Days FREE Trial $280M 10.6x 0.7x
NLOP Unlock Forecast - 30 Days FREE Trial $389M x 0.9x
NLY Unlock Forecast - 30 Days FREE Trial $15099M 10.1x 1.0x
NLY-PF Unlock Forecast - 30 Days FREE Trial $17197M 11.5x 1.2x
NLY-PG Unlock Forecast - 30 Days FREE Trial $16924M 11.3x 1.1x
NLY-PI Unlock Forecast - 30 Days FREE Trial $17210M 11.5x 1.2x
NNN Unlock Forecast - 30 Days FREE Trial $7685M 19.6x 1.7x
NREF Unlock Forecast - 30 Days FREE Trial $265M 2.3x 2.0x
NREF-PA Unlock Forecast - 30 Days FREE Trial $416M 3.7x 3.1x
NSA Unlock Forecast - 30 Days FREE Trial $2294M 33.9x 2.4x
NSA-PA Unlock Forecast - 30 Days FREE Trial $1653M 24.4x 1.7x
NSA-PB Unlock Forecast - 30 Days FREE Trial $1662M 24.6x 1.7x
NTST Unlock Forecast - 30 Days FREE Trial $1473M 7959.9x 1.1x
NXDT Unlock Forecast - 30 Days FREE Trial $161M -1.9x 0.2x
NXDT-PA Unlock Forecast - 30 Days FREE Trial $677M x 0.9x
NXRT Unlock Forecast - 30 Days FREE Trial $753M 16.6x 2.3x
NYC Unlock Forecast - 30 Days FREE Trial $21M -0.1x 0.3x
O Unlock Forecast - 30 Days FREE Trial $53096M 55.2x 1.4x
OGCP Unlock Forecast - 30 Days FREE Trial $1768M 29.7x x
OLP Unlock Forecast - 30 Days FREE Trial $439M 13.1x 1.4x
ONL Unlock Forecast - 30 Days FREE Trial $115M -2.5x 0.2x
ORC Unlock Forecast - 30 Days FREE Trial $1057M 17.3x 1.0x
OUT Unlock Forecast - 30 Days FREE Trial $3917M 31.5x 7.2x
PCH Unlock Forecast - 30 Days FREE Trial $3113M 48.5x 1.6x
PCOK Unlock Forecast - 30 Days FREE Trial $148M x 0.2x
PEB Unlock Forecast - 30 Days FREE Trial $1284M -21.5x 0.5x
PEB-PE Unlock Forecast - 30 Days FREE Trial $2174M x 0.9x
PEB-PF Unlock Forecast - 30 Days FREE Trial $2155M x 0.9x
PEB-PG Unlock Forecast - 30 Days FREE Trial $2182M x 0.9x
PEB-PH Unlock Forecast - 30 Days FREE Trial $2005M x 0.8x
PECO Unlock Forecast - 30 Days FREE Trial $4406M 53.8x 1.9x
PGRE Unlock Forecast - 30 Days FREE Trial $1465M -5.8x 0.5x
PINE Unlock Forecast - 30 Days FREE Trial $241M 169.3x 1.1x
PKST Unlock Forecast - 30 Days FREE Trial $532M -3.7x 0.7x
PLD Unlock Forecast - 30 Days FREE Trial $120893M 37.7x 2.3x
PLDGP Unlock Forecast - 30 Days FREE Trial $53120M 16.6x 1.0x
PMT Unlock Forecast - 30 Days FREE Trial $1084M 8.9x 0.6x
PMT-PA Unlock Forecast - 30 Days FREE Trial $2077M 17.0x 1.1x
PMT-PB Unlock Forecast - 30 Days FREE Trial $2073M 17.0x 1.1x
PMT-PC Unlock Forecast - 30 Days FREE Trial $1627M 13.3x 0.9x
PMTU Unlock Forecast - 30 Days FREE Trial $2243M 18.4x 1.2x
PMTV Unlock Forecast - 30 Days FREE Trial $2220M 18.2x 1.2x
PMTW Unlock Forecast - 30 Days FREE Trial $2202M 18.1x 1.2x
PSA Unlock Forecast - 30 Days FREE Trial $48372M 25.6x 5.2x
PSA-PF Unlock Forecast - 30 Days FREE Trial $3765M 2.0x 0.4x
PSA-PG Unlock Forecast - 30 Days FREE Trial $3650M 1.9x 0.4x
PSA-PH Unlock Forecast - 30 Days FREE Trial $4108M 2.2x 0.4x
PSA-PI Unlock Forecast - 30 Days FREE Trial $3453M 1.8x 0.4x
PSA-PJ Unlock Forecast - 30 Days FREE Trial $3342M 1.8x 0.4x
PSA-PK Unlock Forecast - 30 Days FREE Trial $3355M 1.8x 0.4x
PSA-PL Unlock Forecast - 30 Days FREE Trial $3288M 1.7x 0.4x
PSA-PM Unlock Forecast - 30 Days FREE Trial $2954M 1.6x 0.3x
PSA-PN Unlock Forecast - 30 Days FREE Trial $2738M 1.5x 0.3x
PSA-PO Unlock Forecast - 30 Days FREE Trial $2769M 1.5x 0.3x
PSA-PP Unlock Forecast - 30 Days FREE Trial $2823M 1.5x 0.3x
PSA-PQ Unlock Forecast - 30 Days FREE Trial $2797M 1.5x 0.3x
PSA-PR Unlock Forecast - 30 Days FREE Trial $2838M 1.5x 0.3x
PSA-PS Unlock Forecast - 30 Days FREE Trial $2914M 1.5x 0.3x
PSTL Unlock Forecast - 30 Days FREE Trial $368M 26.2x 1.3x
PW Unlock Forecast - 30 Days FREE Trial $3M -0.2x 0.5x
PW-PA Unlock Forecast - 30 Days FREE Trial $16M x 2.5x
RC Unlock Forecast - 30 Days FREE Trial $387M -13.0x 0.2x
RCB Unlock Forecast - 30 Days FREE Trial $3977M -44.3x 2.2x
RCC Unlock Forecast - 30 Days FREE Trial $4033M -45.2x 2.3x
RCD Unlock Forecast - 30 Days FREE Trial $3680M x 2.1x
RC-PC Unlock Forecast - 30 Days FREE Trial $2369M x 1.3x
RC-PE Unlock Forecast - 30 Days FREE Trial $2330M x 1.3x
REFI Unlock Forecast - 30 Days FREE Trial $284M 7.9x 0.9x
REG Unlock Forecast - 30 Days FREE Trial $12246M 37.7x 1.8x
REGCO Unlock Forecast - 30 Days FREE Trial $4115M 12.7x 0.6x
REGCP Unlock Forecast - 30 Days FREE Trial $4313M 13.3x 0.6x
REXR Unlock Forecast - 30 Days FREE Trial $9610M 28.3x 1.1x
REXR-PB Unlock Forecast - 30 Days FREE Trial $5227M 15.4x 0.6x
REXR-PC Unlock Forecast - 30 Days FREE Trial $4998M 14.7x 0.6x
RHP Unlock Forecast - 30 Days FREE Trial $6173M 25.5x 8.1x
RITM Unlock Forecast - 30 Days FREE Trial $6157M 6.8x 0.7x
RITM-PA Unlock Forecast - 30 Days FREE Trial $14010M 15.5x 1.7x
RITM-PB Unlock Forecast - 30 Days FREE Trial $13932M 15.4x 1.6x
RITM-PC Unlock Forecast - 30 Days FREE Trial $13655M 15.1x 1.6x
RITM-PD Unlock Forecast - 30 Days FREE Trial $13628M 15.1x 1.6x
RLJ Unlock Forecast - 30 Days FREE Trial $1157M 34.6x 0.5x
RLJ-PA Unlock Forecast - 30 Days FREE Trial $3814M 114.0x 1.7x
RPT Unlock Forecast - 30 Days FREE Trial $127M 110.9x 0.4x
RPT-PC Unlock Forecast - 30 Days FREE Trial $1138M 996.0x 3.9x
RWT Unlock Forecast - 30 Days FREE Trial $710M 31.3x 0.7x
RWTN Unlock Forecast - 30 Days FREE Trial $3124M x 3.1x
RWTO Unlock Forecast - 30 Days FREE Trial $3146M x 3.2x
RWTP Unlock Forecast - 30 Days FREE Trial $3117M x 3.1x
RWT-PA Unlock Forecast - 30 Days FREE Trial $3102M x 3.1x
SACH Unlock Forecast - 30 Days FREE Trial $55M 14.5x 0.3x
SACH-PA Unlock Forecast - 30 Days FREE Trial $885M 233.5x 5.0x
SAFE Unlock Forecast - 30 Days FREE Trial $1012M 9.0x 0.4x
SBAC Unlock Forecast - 30 Days FREE Trial $20464M 23.9x -5.1x
SBRA Unlock Forecast - 30 Days FREE Trial $4783M 27.3x 1.7x
SCCC Unlock Forecast - 30 Days FREE Trial $1192M 361.5x 6.8x
SCCD Unlock Forecast - 30 Days FREE Trial $1161M 306.4x 6.6x
SCCE Unlock Forecast - 30 Days FREE Trial $1107M 292.3x 6.3x
SCCF Unlock Forecast - 30 Days FREE Trial $1114M 294.0x 6.3x
SCCG Unlock Forecast - 30 Days FREE Trial $1114M 294.2x 6.3x
SELF Unlock Forecast - 30 Days FREE Trial $57M 31.6x 1.2x
SEVN Unlock Forecast - 30 Days FREE Trial $145M 9.4x 0.6x
SILA Unlock Forecast - 30 Days FREE Trial $1257M 32.0x 0.9x
SITC Unlock Forecast - 30 Days FREE Trial $384M 10.2x 1.3x
SKT Unlock Forecast - 30 Days FREE Trial $3868M 47.6x 5.5x
SLG Unlock Forecast - 30 Days FREE Trial $3171M 186.4x 0.8x
SLG-PI Unlock Forecast - 30 Days FREE Trial $1523M 89.5x 0.4x
SMA Unlock Forecast - 30 Days FREE Trial $1017M x 0.9x
SOHO Unlock Forecast - 30 Days FREE Trial $45M -1.4x 1.2x
SOHOB Unlock Forecast - 30 Days FREE Trial $347M -21.4x 9.4x
SOHON Unlock Forecast - 30 Days FREE Trial $310M -21.8x 8.5x
SOHOO Unlock Forecast - 30 Days FREE Trial $355M -25.6x 9.7x
SPG Unlock Forecast - 30 Days FREE Trial $59417M 26.5x 25.3x
SPG-PJ Unlock Forecast - 30 Days FREE Trial $17848M 7.9x 7.6x
SQFT Unlock Forecast - 30 Days FREE Trial $37M 1.2x 1.1x
SQFTP Unlock Forecast - 30 Days FREE Trial $142M 24.7x 4.0x
STAG Unlock Forecast - 30 Days FREE Trial $7037M 29.2x 2.1x
STLY Unlock Forecast - 30 Days FREE Trial $26M 15.5x 0.6x
STRW Unlock Forecast - 30 Days FREE Trial $172M 24.5x 12.1x
STSR Unlock Forecast - 30 Days FREE Trial $28M x 0.4x
STWD Unlock Forecast - 30 Days FREE Trial $6825M 18.6x 1.0x
SUI Unlock Forecast - 30 Days FREE Trial $15105M 14.4x 2.2x
SUNS Unlock Forecast - 30 Days FREE Trial $138M 11.2x 0.8x
SVC Unlock Forecast - 30 Days FREE Trial $319M -2.2x 0.5x
TCI Unlock Forecast - 30 Days FREE Trial $431M 76.8x 0.5x
TFSA Unlock Forecast - 30 Days FREE Trial $198M x 0.0x
TPTA Unlock Forecast - 30 Days FREE Trial $579M x 3.6x
TRTX Unlock Forecast - 30 Days FREE Trial $717M 10.7x 0.7x
TRTX-PC Unlock Forecast - 30 Days FREE Trial $1460M 21.8x 1.4x
TWO Unlock Forecast - 30 Days FREE Trial $1034M 14.6x 0.4x
TWOD Unlock Forecast - 30 Days FREE Trial $2671M 37.8x 1.1x
TWO-PA Unlock Forecast - 30 Days FREE Trial $2437M 34.5x 1.0x
TWO-PB Unlock Forecast - 30 Days FREE Trial $2392M 33.9x 1.0x
TWO-PC Unlock Forecast - 30 Days FREE Trial $2502M 35.4x 1.0x
UDR Unlock Forecast - 30 Days FREE Trial $11752M 78.5x 3.6x
UHT Unlock Forecast - 30 Days FREE Trial $587M 32.7x 3.7x
UMH Unlock Forecast - 30 Days FREE Trial $1358M 50.5x 1.5x
UMH-PD Unlock Forecast - 30 Days FREE Trial $1848M 68.7x 2.0x
VICI Unlock Forecast - 30 Days FREE Trial $30632M 11.0x 1.1x
VNO Unlock Forecast - 30 Days FREE Trial $6789M 7.5x 1.1x
VNO-PL Unlock Forecast - 30 Days FREE Trial $3440M 3.8x 0.6x
VNO-PM Unlock Forecast - 30 Days FREE Trial $3367M 3.7x 0.6x
VNO-PN Unlock Forecast - 30 Days FREE Trial $3323M 3.7x 0.6x
VNO-PO Unlock Forecast - 30 Days FREE Trial $2858M 3.2x 0.5x
VNORP Unlock Forecast - 30 Days FREE Trial $13223M 14.6x 2.2x
VRE Unlock Forecast - 30 Days FREE Trial $1376M 21.9x 1.2x
VTR Unlock Forecast - 30 Days FREE Trial $36551M 153.6x 3.0x
WELL Unlock Forecast - 30 Days FREE Trial $127744M 133.0x 3.3x
WHLR Unlock Forecast - 30 Days FREE Trial $6M 0.1x -0.7x
WHLRD Unlock Forecast - 30 Days FREE Trial $40M 0.8x -4.8x
WHLRL Unlock Forecast - 30 Days FREE Trial $89M 1.9x -21.2x
WHLRP Unlock Forecast - 30 Days FREE Trial $4M 0.1x -0.6x
WPC Unlock Forecast - 30 Days FREE Trial $14247M 39.0x 1.8x
WSR Unlock Forecast - 30 Days FREE Trial $690M 15.5x 1.6x
WY Unlock Forecast - 30 Days FREE Trial $16861M 50.9x 1.8x

Frequently Asked Questions - Alexander & Baldwin, Inc. Stock Forecast

How accurate are Alexander & Baldwin, Inc. stock predictions?

Our AI model shows a 18% Spearman correlation coefficient for ALEX predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence Alexander & Baldwin, Inc. stock price forecasts?

Our analysis considers Alexander & Baldwin, Inc.'s financial metrics, Real Estate & Construction sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Alexander & Baldwin, Inc. a good investment in 2025?

Based on our AI analysis, Alexander & Baldwin, Inc. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Alexander & Baldwin, Inc. forecasts updated?

Alexander & Baldwin, Inc. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced Alexander & Baldwin, Inc. Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for Alexander & Baldwin, Inc. stock.

🎯 Get Premium Analysis 📊 Explore More Stocks

My Portfolio

Investment Dashboard

Loading your portfolio...